Related Products of 1081-17-0, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.1081-17-0, Name is 1-(4-Methoxyphenyl)-1H-pyrrole-2,5-dione, molecular formula is C11H9NO3. In a article£¬once mentioned of 1081-17-0
Systems pharmacology-based dissection of the active ingredients and targets of Yiqi Zishen formula for application to COPD
In this work, a systems pharmacology model based on the pharmacokinetic analysis, drug targeting, and drug-target-disease network analyses, was applied specifically to uncover the active ingredients and therapeutic targets of Yiqi Zishen formula (YZF). Furthermore, a rat model of cigarette smoke-and bacterial infection-induced chronic obstructive pulmonary disease (COPD) was applied to evaluate the effects of YZF on COPD and its comorbidity. The expression of interleukin (IL)-1beta, IL-6, tumor necrosis factor (TNF)-alpha, soluble TNF-alpha receptor (sTNFR2), matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of MMP (TIMP)-1, endothelin (ET)-1, transforming growth factor (TGF)-beta, vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) were analyzed by immunohistochemistry. The pharmacological system efficiently generated 158 active compounds from YZF, and predicted 192 potential targets. The result showed that there was a significant target overlap between the 12 herbs in the YZF formula, which means that each herb of YZF connected with the similar targets, implying the synergistic effects among them. The target-disease network results indicated that YZF was effective in treating various pathological conditions, including respiratory tract diseases, cardiovascular disease, immune system diseases, and nervous system diseases. The therapeutic mechanisms of YZF were probably associated with modulation of inflammatory response, immune responses, matrix metalloproteinases expression, among others. In follow-up experiments, we found that YZF was effective for the treatment of COPD and its comorbidity such as ventricular hypertrophy, by inhibiting the expression of inflammatory cytokine, matrix metalloproteinases, and hypertrophic stimuli and collagen, in vivo.
A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 1081-17-0
Reference£º
Pyrroline – Wikipedia,
1-Pyrroline | C4H7N – PubChem